Answers are grounded in this paper and cite their sources.
Severe Alpha-1-antitrypsin (AAT) deficiency is a risk factor for chronic obstructive pulmonary disease and emphysema, but risks in mildly reduced AAT levels are unclear. We evaluated the association between mildly reduced serum-AAT levels and chronic airflow limitation (CAL), emphysema and respiratory symptoms, and risks in relation to smoking. We measured serum AAT in people aged 50–65 years in the population-based Swedish CArdioPulmonary bioImage Study (SCAPIS, n = 24,931). We carried out binary logistic regression models to assess pulmonary and cardiovascular outcomes associated with mildly reduced AAT levels. In total, 23,072 individuals had normal serum AAT concentration (≥ 0.86 g/L in men and ≥ 0.94 g/L in women), and 1,859 had mildly reduced AAT levels (0.61–0.85 g/L in men and 0.61–0.93 g/L in women). Mildly reduced AAT levels were not significantly associated with CAL, defined according to either GOLD criteria (CAL GOLD ) or the lower limit of normal (CAL LLN ), or with emphysema on computed tomography (CT): OR (95% CI) 1.01 (0.85–1.21) for CAL GOLD , 0.95 (0.80–1.13) for CAL LLN , and 0.94 (0.75–1.18) for emphysema. Mildly reduced AAT levels were associated with lower odds of DLCO < LLN (OR 0.71, 95% CI 0.57–0.87) and lower odds of respiratory symptoms (0.87 (0.78–0.97) compared with normal AAT levels. In this large population-based cohort, mildly reduced AAT levels were not independently associated with CAL or CT-defined emphysema. These findings suggest that mildly reduced AAT levels alone may not represent a major risk factor for airflow limitation or emphysema in the general population.
No takes yet. Share an insight, caveat, or question.
Tanash et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: